Study on the Efficacy and Safety of QLM1016 in Schizophrenia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study will evaluate the antipsychotic efficacy of QLM1016 in a multicenter, randomized, double-blind, parallel controlled study in patients diagnosed with schizophrenia.
Epistemonikos ID: c6f2dc6131b6530d0782677f88957ae41b0df5bf
First added on: Feb 01, 2025